"Albumin-Bound Paclitaxel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.
| Descriptor ID |
D000068196
|
| MeSH Number(s) |
D02.455.426.392.368.242.888.777.500 D02.455.849.291.850.777.500 D12.776.034.073
|
| Concept/Terms |
Albumin-Bound Paclitaxel- Albumin-Bound Paclitaxel
- Albumin Bound Paclitaxel
- Paclitaxel, Albumin-Bound
- Protein-Bound Paclitaxel
- Paclitaxel, Protein-Bound
- Protein Bound Paclitaxel
|
Below are MeSH descriptors whose meaning is more general than "Albumin-Bound Paclitaxel".
Below are MeSH descriptors whose meaning is more specific than "Albumin-Bound Paclitaxel".
This graph shows the total number of publications written about "Albumin-Bound Paclitaxel" by people in this website by year, and whether "Albumin-Bound Paclitaxel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albumin-Bound Paclitaxel" by people in Profiles.
-
CCR 20th Anniversary Commentary: Setting the Stage for Nanoparticle Albumin-Bound Paclitaxel-How Far Science Has Come. Clin Cancer Res. 2015 May 01; 21(9):1975-7.
-
Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab. J Ocul Pharmacol Ther. 2013 Apr; 29(3):360-2.
-
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma. Cancer. 2010 Jan 01; 116(1):155-63.